ADJUVANT CHEMOIMMUNOTHERAPY AFTER REGIONAL LYMPHADENECTOMY FOR MALIGNANT-MELANOMA

被引：2

作者：

ABDI, EA ^{[1
]}

HANSON, J ^{[1
]}

MCPHERSON, TA ^{[1
]}

机构：

[1] CROSS CANC INST,DEPT EPIDEMIOL,EDMONTON T6G 1Z2,ALBERTA,CANADA

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1987年 / 10卷 / 02期

关键词：

D O I：

10.1097/00000421-198704000-00044

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：117 / 122

页数：6

共 38 条

[1]

BALCH CM, 1979, CANCER, V43, P883, DOI 10.1002/1097-0142(197903)43:3<883::AID-CNCR2820430316>3.0.CO

[2]

2-V

[3] A MULTIFACTORIAL ANALYSIS OF MELANOMA .3. PROGNOSTIC FACTORS IN MELANOMA PATIENTS WITH LYMPH-NODE METASTASES (STAGE-II) [J].

BALCH, CM ;

SOONG, SJ ;

MURAD, TM ;

INGALLS, AL ;

MADDOX, WA .

ANNALS OF SURGERY, 1981, 193 (03) :377-388

[4]

BALCH CM, 1979, SURGERY, V86, P343

[5]

BELLET RE, 1979, HUMAN MALIGNANT MELA, P325

[6] PULMONARY MANIFESTATIONS IN PATIENTS WITH MALIGNANT-MELANOMA DURING BCG IMMUNOTHERAPY - PRELIMINARY-REPORT [J].

BILGI, C ;

BROWN, NE ;

MCPHERSON, TA ;

LENTLE, B .

CHEST, 1979, 75 (06) :685-687

[7]

CLEMENTS DV, 1977, NEOPLASM IMMUNITY ME, P135

[8] IMMUNIZATION WITH IRRADIATED TUMOUR CELLS AND SPECIFIC LYMPHOCYTE CYTOTOXICITY IN MALIGNANT MELANOMA [J].

CURRIE, GA ;

LEJEUNE, F ;

FAIRLEY, GH .

BRITISH MEDICAL JOURNAL, 1971, 2 (5757) :305-&

[9]

DASGUPTA TK, 1977, ANN SURG, V186, P201

[10] PROGNOSTIC FACTORS FOR PATIENTS WITH CLINICAL STAGE-1 MELANOMA OF INTERMEDIATE THICKNESS (1.51-3.99 MM) - A CONCEPTUAL-MODEL FOR TUMOR-GROWTH AND METASTASIS [J].

DAY, CL ;

MARTIN, C ;

LEW, RA ;

HARRIS, MN ;

KOPF, AW ;

FITZPATRICK, TB ;

HARRIST, TJ ;

GOLOMB, FM ;

POSTEL, A ;

HENNESSEY, P ;

GUMPORT, SL ;

RAKER, JW ;

MALT, RA ;

COSIMI, AB ;

WOOD, WC ;

ROSES, DF ;

GORSTEIN, F ;

RIGEL, D ;

FRIEDMAN, RJ ;

MINTZIS, MM ;

SOBER, AJ .

ANNALS OF SURGERY, 1982, 195 (01) :35-43

← 1 2 3 4 →